Grant: Research Tools and Instruments
University of Toronto
$131,827.00
Replacement and Upgrade of a Nanoparticle Formulation System
FY 2024-25
Summary
We are seeking funds to replace and upgrade a nanoparticle formulation system designed for ease of engineering particles for materials and biomaterials applications. This instrument accurately controls the flow of two syringe pumps, allowing for the mixing of two samples at controlled rates and volumes, and directs these samples through a microfluidic device with a structure designed to maximize loading of particles and optimize size distribution. A key advantage of this instrument is its ability to produce materials with narrow property distributions, which would not be possible if the mixing of samples was conducted manually. This instrument allows for the formulation of many kinds of particles; this versatility is key as it will be used as a shared resource, so it is essential to have precise control over formulation parameters, such as size, composition, diameter, and net charge of the lipid (and other) nanoparticles produced.
While researchers have used a first-generation instrument for several years, the manufacturer has discontinued the supply of disposable cartridges necessary for generating highly reproducible microfluidic flows. This instrument is used in scientific and engineering studies, with the intention that the collected data will support or inform future manufacturing of the nanoparticles. Thus, although a simpler tool could be used, the ability to document processing and formulation accurately would be lost if we did not replace the current instrument with a certified one that can replicate the conditions of our original device. The existing instrument, though now outdated, has supported a reliable shared-use protocol for years, enabling numerous teams and trainees to work with these engineered particles almost daily.
The upgraded instrument will be utilized by faculty members from Assistant to Full Professors, and it will support research across various departments, including arts and sciences, engineering, and the medical school. This will also empower collaborative efforts, allowing those researching novel formulations to easily encapsulate payloads. This initiative is crucial for developing materials intended for future biomedical applications. A significant portion of the use will come from a team of students whose innovations in nanoparticles and RNA have led to patentable discoveries, even resulting in the creation of startup companies. One example is NorthMiRs, founded by students, which has already designed, tested, and demonstrated successful RNA delivery into cells treated with immune-active agents in both in vitro and in vivo experiments. Additional nanoparticle testing conducted outside the University at the BC Cancer Agency and Unity Health Toronto using animal models has shown that these particles can treat heart injury, such as cardiomyopathy, in an infection model. As a testament to their success, this student-led startup has received awards and seed funding for the commercialization of their formulation.
Program
Research Tools and Instruments
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RTI-2025-00591
Name nom
Walker, Gilbert
Department département
Chemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2025
Award amount
131827
Program id
RTI
Program name en
Research Tools and Instruments
Program name fr
Outils et instruments de recherche
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1604
Committee name en
Chemistry (RTI)
Committee name fr
Chimie (OIR)
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Replacement and Upgrade of a Nanoparticle Formulation System
Keywords
nanoparticles; lipid nanoparticles; biomaterials engineering; formulation science
Application summary
We are seeking funds to replace and upgrade a nanoparticle formulation system designed for ease of engineering particles for materials and biomaterials applications. This instrument accurately controls the flow of two syringe pumps, allowing for the mixing of two samples at controlled rates and volumes, and directs these samples through a microfluidic device with a structure designed to maximize loading of particles and optimize size distribution. A key advantage of this instrument is its ability to produce materials with narrow property distributions, which would not be possible if the mixing of samples was conducted manually. This instrument allows for the formulation of many kinds of particles; this versatility is key as it will be used as a shared resource, so it is essential to have precise control over formulation parameters, such as size, composition, diameter, and net charge of the lipid (and other) nanoparticles produced.
While researchers have used a first-generation instrument for several years, the manufacturer has discontinued the supply of disposable cartridges necessary for generating highly reproducible microfluidic flows. This instrument is used in scientific and engineering studies, with the intention that the collected data will support or inform future manufacturing of the nanoparticles. Thus, although a simpler tool could be used, the ability to document processing and formulation accurately would be lost if we did not replace the current instrument with a certified one that can replicate the conditions of our original device. The existing instrument, though now outdated, has supported a reliable shared-use protocol for years, enabling numerous teams and trainees to work with these engineered particles almost daily.
The upgraded instrument will be utilized by faculty members from Assistant to Full Professors, and it will support research across various departments, including arts and sciences, engineering, and the medical school. This will also empower collaborative efforts, allowing those researching novel formulations to easily encapsulate payloads. This initiative is crucial for developing materials intended for future biomedical applications. A significant portion of the use will come from a team of students whose innovations in nanoparticles and RNA have led to patentable discoveries, even resulting in the creation of startup companies. One example is NorthMiRs, founded by students, which has already designed, tested, and demonstrated successful RNA delivery into cells treated with immune-active agents in both in vitro and in vivo experiments. Additional nanoparticle testing conducted outside the University at the BC Cancer Agency and Unity Health Toronto using animal models has shown that these particles can treat heart injury, such as cardiomyopathy, in an infection model. As a testament to their success, this student-led startup has received awards and seed funding for the commercialization of their formulation.